Top Markets
Coin of the day
Algernon Pharmaceuticals Inc. Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc.

AGN
Classement en actions #38371
Algernon Pharmaceuticals Inc. is a clinical-stage pharmaceutical company... Algernon Pharmaceuticals Inc. is a clinical-stage pharmaceutical company dedicated to discovering and developing new treatments. Their research and development efforts concentrate on a range of serious conditions, including non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, and acute lung injury associated with COVID-19, operating across Canada and Australia. The company's primary drug candidate, NP-120, acts as an N-methyl-d-aspartate (NMDA) receptor glutamate antagonist. This compound specifically targets the NMDA-type subunit 2B (Glu2NB) and also demonstrates agonist activity for the Sigma-1 receptor, a chaperone protein elevated during endoplasmic reticulum stress. Furthermore, Algernon is advancing AP-188, a psychedelic agent from the tryptamine family, for treating ischemic stroke in humans. Preclinical investigations for AP-188, as part of their stroke clinical research program, are underway through a collaboration with Charles River Laboratories. Established in 2015, Algernon Pharmaceuticals Inc. is headquartered in Vancouver, Canada.
Prix de l'action
$0.29357476
Dernière synchronisation: 2026-05-14
Capitalisation boursière
$1.02M
Changement (1 jour)
1.27%
Changement (1 an)
-42.07%
Pays
CA
Échange Algernon Pharmaceuticals Inc. (AGN)

Catégorie

Historique du prix de l'action pour Algernon Pharmaceuticals Inc. (AGN)
Prix de clôture le plus élevé : $0.29 le 2026-05-01

Prix de clôture le plus bas : $169.74 le 2016-02-01
Historique du prix de l'action de Algernon Pharmaceuticals Inc. de 2016 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -22.61%
2025 16.84%
2024 -12.82%
2023 -88.01%
2022 -47.29%
2021 -85.85%
2020 524.96%
2019 -58.71%
2018 -64.50%
2017 5.94%
2016 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$505.24 29.45%
US
$846.09 29.68%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE